Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • TEVA PHARMACTL INDUS LTD ADS Analyst Recommendations

  • Analyst Consensus: TEVA

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 1.545 Buy 22
    30 Days Ago — — —
    60 Days Ago — — —
    90 Days Ago — — —
    120 Days Ago — — —

  • Analyst Ratings: TEVA

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Jefferies & Co — Buy 11/04/2009 61.00
    Barclays Capital — Overweight 05/19/2009 60.00
    Jefferies & Co — Buy 04/23/2009 52.00
    Credit Suisse — Outperform 02/25/2009 —
    Deutsche Securities — Buy 02/18/2009 57.00
    Deutsche Securities — Buy 01/20/2009 54.00
    JP Morgan — Overweight 12/17/2008 —
    Citigroup — Buy 12/17/2008 —
    Needham — Strong Buy 09/24/2008 61.00
    Stanford Research — Buy 09/24/2008 55.00
    Wachovia Mkt Perform Outperform 09/22/2008 —
    Oppenheimer — Outperform 09/11/2008 58.00
    Deutsche Securities Hold Buy 07/21/2008 56.00
    FTN Midwest Buy Neutral 07/11/2008 —
    Deutsche Securities Buy Hold 07/08/2008 47.00
    HSBC Securities Neutral Overweight 06/30/2008 —
    HSBC Securities — Neutral 05/07/2008 50.00
    HSBC Securities — Neutral 04/22/2008 52.00
    Citigroup Buy Hold 03/14/2008 50.00
    Friedman Billings Outperform — 02/08/2008 —
    HSBC Securities Overweight Neutral 01/14/2008 —
    AmTech Research Buy Neutral 01/07/2008 52.00
    Friedman Billings — Outperform 12/26/2007 53.00
    Banc of America Sec — Buy 12/18/2007 55.00
    HSBC Securities — Overweight 10/31/2007 50.00
    Friedman Billings Mkt Perform Outperform 10/31/2007 52.00
    CIBC Wrld Mkts — Sector Outperform 09/07/2007 53.00
    Friedman Billings — Mkt Perform 08/02/2007 46.00
    Bear Stearns Peer Perform Outperform 07/09/2007 48.00
    Credit Suisse Neutral Outperform 06/06/2007 48.00
    Next